Published online Dec 26, 2020. doi: 10.4252/wjsc.v12.i12.1455
Peer-review started: June 16, 2020
First decision: September 18, 2020
Revised: September 28, 2020
Accepted: October 23, 2020
Article in press: October 23, 2020
Published online: December 26, 2020
Processing time: 194 Days and 1.5 Hours
Metformin is a first-line medication for type II diabetes. Numerous studies have shown that metformin not only has hypoglycemic effects, but also modulates many physiological and pathological processes ranging from aging and cancer to fracture healing. During these different physiological activities and pathological changes, stem cells usually play a core role. Thus, many studies have investigated the effects of metformin on stem cells. Metformin affects cell differentiation and has promising applications in stem cell medicine. It exerts anti-aging effects and can be applied to gerontology and regenerative medicine. The potential anti-cancer stem cell effect of metformin indicates that it can be an adjuvant therapy for cancers. Furthermore, metformin has beneficial effects against many other diseases including cardiovascular and autoimmune diseases. In this review, we summarize the effects of metformin on stem cells and provide an overview of its molecular mechanisms and clinical prospects.
Core Tip: The effect of metformin on stem cells is quickly gaining attention, because metformin modulates various physiological activities and pathological changes via targeting stem cells. Emerging studies suggest that metformin has broad prospects in the fields of stem cell medicine, gerontology, regenerative medicine, and cancer therapy, etc. In this review, we summarize the effects of metformin on stem cells and provide an overview of its molecular mechanisms and clinical prospects.